English, Article edition: Cost Effectiveness of Epoetin-alpha to Augment Preoperative Autologous Blood Donation in Elective Cardiac Surgery Douglas Coyle; Karen M. Lee; Dean A. Fergusson; ...

User activity

Share to:
 
Bookmark: http://trove.nla.gov.au/version/94444
Physical Description
  • article
Language
  • English

Edition details

Title
  • Cost Effectiveness of Epoetin-alpha to Augment Preoperative Autologous Blood Donation in Elective Cardiac Surgery
Author
  • Douglas Coyle
  • Karen M. Lee
  • Dean A. Fergusson
  • Andreas Laupacis
Physical Description
  • article
Notes
  • Objective: The objective of this study was to assess the cost effectiveness of using epoetin-alpha (erythropoietin) to augment preoperative autologous donation (PAD) of blood prior to elective cardiac surgery. Design and setting: We designed a decision-analytic model incorporating the risk of receiving allogeneic blood, the costs of blood products, the likelihood of developing transfusion-related diseases, the costs of transfusion-related diseases and their impact on life expectancy, and the effect of epoetin-alpha on the probability of transfusion. Interventions: The efficacy of epoetin-alpha was derived from data from a meta-analysis of published randomised trials comparing the use of epoetin-alpha to augment PAD with the use of PAD alone. Estimates for the other parameters were obtained by a systematic review of the literature. Main outcome measures and results: The use of epoetin-alpha reduced the proportion of patients receiving allogeneic transfusions by 60% (from 31.6 to 12.7%). However, this led to only a modest benefit of 0.000035 life years gained per patient and an incremental cost per life year gained of $Can44.6 million (1998 Canadian dollars). A detailed sensitivity analysis confirmed that the cost-effectiveness ratio was larger than that which is generally considered acceptable. Conclusions: Our study indicates that the use of epoetin-alpha to reduce perioperative allogeneic transfusions in cardiac surgery is not cost effective.
  • Antianaemics, Blood transfusion, Cost effectiveness, Epoetin alfa, Heart surgery, Pharmacoeconomics
  • RePEc:wkh:phecon:v:18:y:2000:i:2:p:161-171
Language
  • English
Contributed by
OAIster

Get this edition

  • Set up My libraries

    How do I set up "My libraries"?

    In order to set up a list of libraries that you have access to, you must first login or sign up. Then set up a personal list of libraries from your profile page by clicking on your user name at the top right of any screen.

  • All (1)
  • Unknown (1)
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.
None of your libraries hold this item.

User activity


e.g. test cricket, Perth (WA), "Parkes, Henry"

Separate different tags with a comma. To include a comma in your tag, surround the tag with double quotes.

Be the first to add a tag for this edition

Be the first to add this to a list

Comments and reviews

What are comments? Add a comment

No user comments or reviews for this version

Add a comment